Reflecting on five years of quality control for nitrosamine

Mrunal Jaywant, VP of R&D at USP India says collaboration can help overcome challenges with nitrosamine impurities and related drug recalls.

Related Keywords

India , States Pharmacopeia , Mrunal Jaywant , Expert Committee , Development Laboratories , Compendial Development , European Medicines Agency , Drug Administration , Us Food Drug Administration , Analytical Research , Nitrosamines Exchange , Vice President , United States Pharmacopeia , Global Substances Registration System , Nitrosamine Impurities , Informational General Chapter , Reference Standards , Pharmaceutical Analytical Impurities , Synthetic Chemistry , Human Drugs , Drug Evaluation ,